Family Care Hospitals Ltd
Incorporated in 1994, Family Care Hospitals Ltd is in the business of providing Healthcare Services.[1]
- Market Cap ₹ 14.7 Cr.
- Current Price ₹ 2.72
- High / Low ₹ 5.83 / 2.51
- Stock P/E
- Book Value ₹ 1.75
- Dividend Yield 0.00 %
- ROCE -25.6 %
- ROE -38.4 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 39.1%
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -1.07%
- The company has delivered a poor sales growth of -64.1% over past five years.
- Promoter holding is low: 17.5%
- Contingent liabilities of Rs.5.09 Cr.
- Promoters have pledged 65.5% of their holding.
- Company has high debtors of 1,755 days.
- Working capital days have increased from 3,504 days to 9,855 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 1.07 | 1.80 | 5.19 | 14.19 | 13.25 | 35.36 | 42.07 | 42.04 | 40.01 | 7.90 | 0.21 | |
| 0.24 | 0.86 | 1.54 | 3.84 | 12.73 | 10.98 | 27.18 | 33.37 | 33.59 | 33.12 | -21.33 | 3.60 | |
| Operating Profit | -0.17 | 0.21 | 0.26 | 1.35 | 1.46 | 2.27 | 8.18 | 8.70 | 8.45 | 6.89 | 29.23 | -3.39 |
| OPM % | -242.86% | 19.63% | 14.44% | 26.01% | 10.29% | 17.13% | 23.13% | 20.68% | 20.10% | 17.22% | 370.00% | -1,614.29% |
| -24.63 | 0.20 | 0.19 | 0.24 | 0.04 | -0.12 | -0.28 | 0.30 | 0.98 | 3.19 | -71.71 | -4.04 | |
| Interest | 0.00 | 0.01 | 0.01 | 0.12 | 0.51 | 0.84 | 0.83 | 0.50 | 0.60 | 0.53 | 0.86 | 0.37 |
| Depreciation | 0.03 | 0.38 | 0.25 | 0.39 | 0.94 | 1.28 | 1.42 | 1.44 | 1.41 | 1.42 | 1.13 | 0.88 |
| Profit before tax | -24.83 | 0.02 | 0.19 | 1.08 | 0.05 | 0.03 | 5.65 | 7.06 | 7.42 | 8.13 | -44.47 | -8.68 |
| Tax % | 0.00% | 0.00% | 21.05% | 20.37% | 60.00% | 33.33% | 27.96% | 26.35% | 29.11% | -54.24% | -0.72% | 0.00% |
| -24.83 | 0.02 | 0.16 | 0.86 | 0.02 | 0.03 | 4.07 | 5.20 | 5.26 | 12.55 | -44.15 | -8.68 | |
| EPS in Rs | -3.41 | 0.00 | 0.02 | 0.12 | 0.00 | 0.00 | 0.56 | 0.71 | 0.97 | 2.32 | -8.17 | -1.61 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.17% | 5.13% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | -64% |
| 3 Years: | -83% |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -33% |
| 3 Years: | -26% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 35% |
| 3 Years: | 39% |
| Last Year: | -38% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 54.01 | 54.01 | 54.01 | 54.01 |
| Reserves | -28.18 | -28.16 | -28.01 | -27.15 | -27.13 | -27.09 | -23.03 | -17.86 | -8.21 | 4.36 | -40.56 | -44.56 |
| 0.56 | 0.56 | 0.10 | 0.28 | 5.60 | 9.53 | 5.50 | 4.26 | 4.32 | 3.65 | 3.39 | 5.17 | |
| 0.04 | 0.08 | 1.31 | 4.66 | 3.22 | 2.59 | 5.81 | 21.34 | 24.46 | 7.94 | 29.26 | 28.46 | |
| Total Liabilities | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.10 | 43.08 |
| 1.74 | 1.84 | 2.44 | 7.24 | 8.61 | 9.52 | 8.01 | 6.82 | 6.93 | 5.95 | 4.00 | 2.90 | |
| CWIP | 0.00 | 0.00 | 0.60 | 0.86 | 0.06 | 0.04 | 0.09 | 0.09 | 0.09 | 0.06 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2.78 | 2.74 | 2.46 | 1.79 | 5.12 | 7.57 | 12.28 | 32.93 | 67.56 | 63.95 | 42.10 | 40.18 | |
| Total Assets | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.10 | 43.08 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.07 | 0.34 | 0.46 | 3.04 | -4.12 | -1.29 | 3.90 | 1.68 | -5.26 | -0.37 | -17.32 | -5.44 | |
| -1.77 | -0.48 | -1.45 | -5.45 | -1.51 | -2.32 | -0.26 | -0.25 | -1.54 | -0.41 | 0.65 | 0.00 | |
| 4.52 | 0.00 | 0.78 | 0.26 | 5.86 | 4.75 | -4.82 | -1.67 | 25.87 | -1.04 | -0.55 | 6.07 | |
| Net Cash Flow | 2.68 | -0.14 | -0.21 | -2.14 | 0.23 | 1.14 | -1.17 | -0.23 | 19.08 | -1.83 | -17.22 | 0.63 |
| Free Cash Flow | -1.84 | -0.14 | -0.99 | -2.41 | -5.63 | -3.61 | 3.64 | 1.42 | -6.80 | -0.78 | -16.67 | -5.44 |
| CFO/OP | 41% | 162% | 192% | 241% | -280% | -56% | 67% | 41% | -39% | -74% | -60% | 160% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | 112.67 | 93.21 | 186.19 | 251.96 | 310.35 | 93.33 | 1,755.48 |
| Inventory Days | 149.08 | 29.44 | 3.74 | 6.18 | 16.46 | 138,809.50 | ||||||
| Days Payable | 976.76 | 211.94 | 382.44 | 386.99 | 112.66 | 86,286.00 | ||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | -715.01 | -89.29 | -192.52 | -128.86 | 214.15 | 93.33 | 54,278.98 |
| Working Capital Days | -2,920.00 | -160.33 | -271.72 | -311.55 | -145.85 | -16.25 | 54.71 | 99.86 | 149.42 | 254.98 | 402.42 | 9,855.00 |
| ROCE % | -3.97% | 0.67% | 4.60% | 25.48% | 7.09% | 8.04% | 46.58% | 45.78% | 23.40% | 15.44% | 79.25% | -25.62% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees employees |
|
|||||||||
| Number of Operational Hospitals hospitals |
||||||||||
| Total Bed Capacity beds |
||||||||||
| Number of Imaging/Diagnostic Centres centres |
||||||||||
| Cumulative Patients/Patrons Served patrons |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Intimation Of Postponed Of The Board Meeting To Be Held On July, 2026
1d - Board meeting postponed to July 31, 2026 for June quarter unaudited results.
-
Board Meeting Intimation for Approval Of Financial Result For The Quarter Ended June 30, 2026
21 Jul - Board meeting on July 24, 2026 to approve Q1 FY27 unaudited results; trading window closed from July 1.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Jul - Attached herewith Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended June 30, 2026
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
30 Jun - Sowmya Deshpande sold 184,383 shares from June 23-29, 2026; holding fell to 6.03%.
-
Closure of Trading Window
29 Jun - Trading window closes July 1, 2026 until 48 hours after Q1 FY2026-27 results.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2][3]
FCHL is in the business of providing healthcare products and services through integrating AI technology and traditional healthcare delivery systems. It has 150 beds, 30 specialities, 300 allied staff, and 40 ICU beds. The company is working closely with Ready Technologies, a unit of Onelife Capital Advisors Ltd (a promoter group company), to develop user-friendly software/ applications which it plans to market aggressively in India and abroad.